Holmdahl L, Falkenberg M, Ivarsson M L, Risberg B
Department of Surgery, Ostra Hospital, University of Göteborg, Sweden.
APMIS. 1997 Jan;105(1):25-30. doi: 10.1111/j.1699-0463.1997.tb00535.x.
Serosal trauma elicits an inflammatory response which leads to the deposition of fibrin at injured sites, the residuals of which appear to be essential in excessive tissue repair and formation of intraabdominal adhesions. Local plasminogen activity may modulate this early phase of tissue repair. The present study was undertaken to investigate the distribution and cellular expression of plasminogen activators and their inhibitors in human peritoneal normal and inflamed tissue. Tissue-type plasminogen activator (t-PA) was expressed in subserosal capillary walls, and in normal mesothelium, but not in inflammation. Immunoreactivity for the plasminogen activator inhibitor type 1 (PAI-1) was present in normal mesothelium, and substantially increased in inflammation, where, in addition, immunoreactivity was found throughout the submesothelial tissue. This PAI-1 was partly co-localized with macrophages, as was the urokinase plasminogen activator (u-PA), suggesting an involvement of these cells in peritoneal tissue fibrinolysis. Inflammation or abrasion of the mesothelium during surgery is likely to cause a depletion of the local t-PA source and expose the potentially PAI-1-containing submesothelial tissue, thus promoting persistence of fibrin and formation of adhesions.
浆膜创伤引发炎症反应,导致纤维蛋白在损伤部位沉积,其残留物在过度组织修复和腹腔内粘连形成中似乎至关重要。局部纤溶酶原活性可能调节组织修复的这一早期阶段。本研究旨在调查纤溶酶原激活剂及其抑制剂在人腹膜正常组织和炎症组织中的分布及细胞表达。组织型纤溶酶原激活剂(t-PA)在浆膜下毛细血管壁和正常间皮中表达,但在炎症组织中不表达。1型纤溶酶原激活剂抑制剂(PAI-1)的免疫反应性在正常间皮中存在,在炎症组织中显著增加,此外,在整个间皮下组织中也发现了免疫反应性。这种PAI-1部分与巨噬细胞共定位,尿激酶型纤溶酶原激活剂(u-PA)也是如此,表明这些细胞参与了腹膜组织纤维蛋白溶解。手术期间间皮的炎症或擦伤可能导致局部t-PA来源枯竭,并暴露潜在含PAI-1的间皮下组织,从而促进纤维蛋白的持续存在和粘连形成。